DENTSPLY SIRONA Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Daniel T. Scavilla
- Full Time Employees
- 14,000
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 13320 Ballantyne Corporate Place Charlotte NC United States of America 28277-3607
- IPO Date
- Aug 12, 1987
- CIK
- 0000818479
- Website
- dentsplysirona.com
- Similar Companies
- Business
- DENTSPLY SIRONA Inc. DENTSPLY SIRONA Inc. develops, manufactures, and markets a comprehensive portfolio of professional dental products and technologies worldwide, serving dental professionals, laboratories, clinics, and distributors in more than 150 countries. The company, formed by the 2016 merger of DENTSPLY International (founded in 1899 in New York City) and Sirona Dental Systems (founded in 1877 in Erlangen, Germany) and headquartered in Charlotte, North Carolina, offers end-to-end solutions including CAD/CAM systems such as CEREC Primescan, Primemill, and inLab; digital imaging with Orthophos, GALILEOS, and XIOS sensors; treatment centers like Axano, INTEGO, and SINIUS; implants via Astra Tech, Ankylos, and DS OmniTaper systems; consumables encompassing restoratives (SureFil, Celtra Duo, Spectra), endodontics (ProTaper Ultimate, WaveOne Gold, TruNatomy), orthodontics (SureSmile aligners), and infection prevention products; laboratory equipment including CEREC Speedfire furnaces and inFire HTC; handpieces and instruments under the Midwest brand; hygiene systems like DAC Universal; and healthcare consumables through Wellspect such as urological catheters. DENTSPLY SIRONA Inc. operates across key segments including connected technology solutions, essential dental equipment, and consumables, targeting general dentists, specialists, oral surgeons, periodontists, endodontists, and orthodontic practices with a focus on digital dentistry, innovation, and clinical education. In recent strategic developments, the company completed a review of alternatives for its Wellspect Healthcare subsidiary in September 2025 and elected to retain it for enhanced long-term value, amid a multi-year transformation emphasizing operational efficiencies, customer engagement, and portfolio optimization; appointed Aldo M. Denti as Executive Vice President and Chief Commercial Officer in October 2025 to strengthen commercial leadership and align business units; launched innovations like Primescan 2, DS Core platform, Primeprint 3D printing solutions, and enhancements to SureSmile aligners and X-Smart Pro+ endodontic motor; and expanded clinical education through DS World events and DS Academy Campus while advancing sustainability initiatives under the BEYOND program and partnerships like Smile Train.
DENTSPLY SIRONA Inc. (XRAY) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
XRAY Stock Down as Q1 Earnings Miss Estimates, Margins Contract
DENTSPLY SIRONA Inc. (XRAY) Q1 2026 Earnings Call Transcript
Dentsply (XRAY) Reports Q1 Earnings: What Key Metrics Have to Say
Dentsply International (XRAY) Lags Q1 Earnings Estimates
Dentsply Sirona Reports First Quarter 2026 Results
Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock?
Earnings Preview: Becton Dickinson (BDX) Q2 Earnings Expected to Decline
Dentsply International (XRAY) Expected to Beat Earnings Estimates: Should You Buy?
Cwm LLC Lowers Stake in DENTSPLY SIRONA Inc. $XRAY
Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Recommendation of “Hold” by Analysts
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares?
XRAY & Siemens Healthineers Secure FDA Nod for Dental-Dedicated MRI
DENTSPLY SIRONA Inc. (XRAY) Presents at Leerink Global Healthcare Conference 2026 Transcript
3 Healthcare Stocks Paying the Highest Dividends of 2026